Envista Holdings Corp (NVST)
19.00
-0.06
(-0.31%)
USD |
NYSE |
May 07, 16:00
19.01
+0.01
(+0.05%)
Pre-Market: 20:00
Envista Holdings Enterprise Value: 3.823B for May 7, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 07, 2024 | 3.823B |
| May 06, 2024 | 3.833B |
| May 03, 2024 | 3.823B |
| May 02, 2024 | 3.962B |
| May 01, 2024 | 3.952B |
| April 30, 2024 | 3.940B |
| April 29, 2024 | 4.101B |
| April 26, 2024 | 4.062B |
| April 25, 2024 | 3.999B |
| April 24, 2024 | 4.044B |
| April 23, 2024 | 4.033B |
| April 22, 2024 | 4.014B |
| April 19, 2024 | 3.989B |
| April 18, 2024 | 3.953B |
| April 17, 2024 | 3.925B |
| April 16, 2024 | 3.958B |
| April 15, 2024 | 3.848B |
| April 12, 2024 | 3.855B |
| April 11, 2024 | 4.011B |
| April 10, 2024 | 4.014B |
| April 09, 2024 | 4.185B |
| April 08, 2024 | 4.051B |
| April 05, 2024 | 4.075B |
| April 04, 2024 | 4.078B |
| April 03, 2024 | 4.037B |
| Date | Value |
|---|---|
| April 02, 2024 | 4.052B |
| April 01, 2024 | 4.135B |
| March 31, 2024 | 4.233B |
| March 28, 2024 | 4.248B |
| March 27, 2024 | 4.277B |
| March 26, 2024 | 4.141B |
| March 25, 2024 | 4.175B |
| March 22, 2024 | 4.231B |
| March 21, 2024 | 4.262B |
| March 20, 2024 | 4.269B |
| March 19, 2024 | 4.305B |
| March 18, 2024 | 4.250B |
| March 15, 2024 | 4.238B |
| March 14, 2024 | 4.287B |
| March 13, 2024 | 4.305B |
| March 12, 2024 | 4.262B |
| March 11, 2024 | 4.301B |
| March 08, 2024 | 4.215B |
| March 07, 2024 | 4.198B |
| March 06, 2024 | 4.149B |
| March 05, 2024 | 4.114B |
| March 04, 2024 | 4.133B |
| March 01, 2024 | 4.162B |
| February 29, 2024 | 4.116B |
| February 28, 2024 | 4.154B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
3.008B
Minimum
Mar 23 2020
8.480B
Maximum
Mar 21 2022
6.182B
Average
6.316B
Median
Jan 03 2023
Enterprise Value Benchmarks
| Boston Scientific Corp | 116.48B |
| Dentsply Sirona Inc | 7.665B |
| Biolase Inc | 15.19M |
| Milestone Scientific Inc | 44.41M |
| Wellness Center USA Inc | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 23.60M |
| Revenue (Quarterly) | 623.60M |
| Total Expenses (Quarterly) | 575.50M |
| EPS Diluted (Quarterly) | 0.14 |
| Gross Profit Margin (Quarterly) | 57.14% |
| Profit Margin (Quarterly) | 3.78% |
| Earnings Yield | -3.79% |
| Operating Earnings Yield | 8.03% |
| Normalized Earnings Yield | -3.790 |